Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 20

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

407

HTML

4591

Figures (1-3)

243

Tables (1-3)

250

Sum=5491

May 28, 2010 (publication date) through Jan 12, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. May 28, 2010; 16(20): 2468-2475
Published online May 28, 2010. doi: 10.3748/wjg.v16.i20.2468

Full Size Figure Download Figure

Figure 1 Alanine transaminase (ALT), albumin and bilirubin levels and prothrombin time 48 wk after adefovir dipivoxil treatment[43].

Citation: Jiang L, Yan LN. Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation. World J Gastroenterol 2010; 16(20): 2468-2475
URL: https://www.wjgnet.com/1007-9327/full/v16/i20/2468.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i20.2468